Navigation Links
NHS Will Do Well to Curb Use Of Umbilical Cord Blood For Treatment of Cancers

should discourage commercial banking of umbilical cord blood. On the contrary, women should be motivated to donate to public// blood banks without the motive of financial gains.

Umbilical cord blood endowed with stem cells are beneficial in treating diseases like childhood leukemia. Bone marrow which is used for treating such diseases is sometimes replaced with cord blood, which is inexpensive and relatively easy to obtain. Also cord blood is not known to spark off any harmful immune response or rejection in the recipient.

For these reasons interest has been growing in banking cord blood as insurance against future disease, but this has worrying implications for NHS services and little chance of benefit, says Dr Leroy Edozien, a Consultant Obstetrician and Gynaecologist at St Mary's Hospital, Manchester.

Cord blood banks generally fall into two groups. Public banks collect cord blood which has been altruistically donated. The blood is used to treat unrelated recipients or is collected from families with a known genetic disease that is treatable by blood stem cell transplantation.

Since 1996, the NHS has been banking donated cord blood through designated public banks run by the National Blood Service and there is universal approval of the storage of this blood.

In contrast, commercial (private) banks operate collection and storage of a baby's cord blood for later use by that person or their siblings should they develop an illness. This 'just-in-case' collection has been criticised by numerous medical bodies and is not recommended.

Scientific arguments against commercial cord blood banking include the chances of the blood being used are very small, the alternatives such as bone marrow, and the speculative claims about how cord blood could be used to treat disease.

But, whatever the scientific merits or demerits, commercial blood banking also raises serious resource, legal, and ethical issues for NHS maternity units, warns the author.

Taking the arguments for and against into consideration, the balance is tilted strongly against NHS trusts collecting cord blood for commercial banking. It should therefore be NHS policy not to facilitate umbilical cord blood collection by its staff, he concludes.



Source-Eurekalert
'"/>




Related medicine news :

1. Umbilical Cord Blood Offers Hope For Patients Who Require Bone Marrow Transplants
2. Umbilical Cord Blood Could Predict Childhood Allergies
3. A Novel System For Clinical Banking Of Umbilical Cord Blood
4. Delay Umbilical Cord Clamping in Pre Term Babies
5. Doctor Dissuades Mothers from Umbilical Cord Banking
6. Umbilical Cord Blood Industry Matures
7. Parents Bank Kids Umbilical Cord Blood
8. Umbilical Cord Blood Banking of Negligible Value: Experts
9. Delayed Cutting of Umbilical Cord Has Benefits
10. Recommendations for Treatment of Blood Pressue
11. Blood Cells Capable of Regenerating Liver
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... Pa. (PRWEB) , ... December 08, 2016 , ... ... Medicine Southern Chester County, a Property owned by an affiliate of Seavest, has ... square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was named ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... access for customers and employees that are both engaging and easy to use. ... Smart Technology, the software company revealed today its plans to roll out new ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... has been recognized for adherence to the highest standards of trauma, maternity, ... organizations, announced the center's president and CEO, Dr. Daniel Messina. , Among the ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016   Hudes Laser ... December featuring the multi-wavelength Astanza Trinity laser and ... specializes in laser tattoo removal, IPL hair removal, ... ultrasound therapy. Hudes Laser Aesthetica is setting high ... and promises to deliver effective, long-lasting ...
(Date:12/9/2016)... OSAKA, Japan , Dec. 9, 2016 ... ; President & Representative Director, CEO: Dr. ... with amyotrophic lateral sclerosis (ALS) given edaravone intravenously in ... functional loss as measured by the ALS Functional Rating ... th International Symposium on ALS/MND in ...
(Date:12/9/2016)... 9, 2016  Axovant Sciences Ltd. (NYSE: ... focused on the treatment of dementia, today announced ... Phase 2b trial evaluating treatment with intepirdine (RVT-101), ... donepezil plus placebo in people with mild-to-moderate Alzheimer,s ... intepirdine to treatment was associated with reduced progression ...
Breaking Medicine Technology: